News Search Results
Nov 12, 2025, 17:48 ET Kodiak Sciences to Present at Upcoming Investor Conferences
Calif., Nov. 12, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that Victor Perlroth, M.D., Chief
More news about: Kodiak Sciences Inc.
Nov 12, 2025, 16:05 ET Tyra Biosciences Announces Participation at Upcoming Investor Events
CARLSBAD, Calif., Nov. 12, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
More news about: Tyra Biosciences
Nov 12, 2025, 16:05 ET Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update
Nov. 12, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
Nov 12, 2025, 12:15 ET Palatin Technologies Announces Closing of Upsized $18.2 Million Public Offering with the Full Exercise of the Underwriters' Over-Allotment Option
complete clinical trials and submit applications for regulatory approvals; products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies; commercial acceptance of Palatin's products; and other factors discussed in Palatin's periodic filings with the SEC. All forward-looking
More news about: Palatin Technologies, Inc.
Nov 12, 2025, 10:53 ET Head and Neck Cancer Drugs/Therapeutics Market Backed by Growing Adoption of Immunotherapy, Advancements in Targeted Treatment Approaches - Market Research Intellect
Strategic collaborations are becoming a cornerstone for innovation in the Head and Neck Cancer Drugs/Therapeutics Market. Pharmaceutical companies, biotechnology firms, academic institutions, and research laboratories are forming alliances to share technology platforms, clinical expertise, and discovery resources.
More news about: Market Research Intellect
Nov 12, 2025, 10:01 ET Life Science Instrumentation Market worth $92.5 billion by 2031 with 6.5% CAGR | MarketsandMarkets™
diagnostic laboratories, pharmaceutical & biotechnology companies, academic & research institutes, agriculture & food industries, environmental testing laboratories, clinical research organizations, and other end users. The pharmaceutical & biotechnology companies segment accounted for the largest
More news about: MarketsandMarkets
Nov 12, 2025, 10:00 ET JULABO USA and Astraglass Innovations Announce Strategic Partnership to Advance Laboratory Solutions for the Life Sciences Industry
manufacturing capabilities to deliver high-performance, custom-engineered systems for research and process development. With expertise spanning biotechnology, pharmaceuticals, chemical process research, and analytical instrumentation, Astraglass provides turnkey glassware solutions that integrate seamlessly
More news about: Julabo USA
Nov 12, 2025, 10:00 ET The Lockwood Group Expands Capabilities by Welcoming Research To Practice
The Lockwood Group is a global pharma services organization with over 700 employees, that partners with pharmaceutical and biotechnology companies to translate complex science into compelling strategies that drive clinical and commercial success. Learn more at
More news about: The Lockwood Group
Nov 12, 2025, 09:00 ET AES Cleanroom Technology Expands Southeast Footprint with New Office in Research Triangle Park
opened a new regional office in Research Triangle Park (RTP), reinforcing its commitment to serving the Southeast's fast-growing life sciences, biotechnology, and advanced manufacturing sectors.
More news about: AES Cleanroom Technology
Nov 12, 2025, 09:00 ET Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and Trademark Office (USPTO) will issue
More news about: Anixa Biosciences, Inc.
Nov 12, 2025, 09:00 ET Kytopen and Excellos Explore New Pathways to Non-Viral Cell Therapy Manufacturing
across a range of cell types, payloads, and therapeutic applications. Kytopen has recently disclosed strategic partnerships with industry-leading biotechnology companies, contract development and manufacturing organizations (CDMOs), and cell therapy-focused medical centers. Kytopen continues to engage strategic
More news about: Kytopen
Nov 12, 2025, 08:30 ET Unified Data + Trustworthy AI: Driving Precision Across Portfolio, Trial and Commercial Planning, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Nov 12, 2025, 08:05 ET Rigel to Present at the Jefferies Global Healthcare Conference in London
Calif., Nov. 12, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company
More news about: Rigel Pharmaceuticals, Inc.
Nov 12, 2025, 08:00 ET Genezen Announces Manufacturing Partnership with Humane Genomics to Advance Oncolytic Virus Therapy for Pediatric Liver Cancer
2025 /PRNewswire/ -- Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolytic viral therapies, today announced a partnership for process transfer and cGMP manufacturing of HGI627, a novel therapy
More news about: Genezen
Nov 12, 2025, 07:05 ET Epicutis Expands Global Footprint With New Offices in Sydney and Kyoto
Science-Backed, Clean Beauty This expansion underscores Epicutis' global vision: to bridge the gap between biotechnology and beauty, providing skincare that is both luxurious and effective, clinically proven, non-toxic, and sustainably made. Find
More news about: Epicutis Skincare
Nov 12, 2025, 02:48 ET BPC Instruments reports results for the period January - September 2025
instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing
More news about: BPC Instruments AB
Nov 12, 2025, 01:00 ET Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
Roche Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche
Nov 12, 2025, 01:00 ET Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
Roche Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche
Nov 11, 2025, 22:07 ET Concordia Shanghai Students Win Gold at International iGEM Competition in Paris
medal achievement highlights Concordia Shanghai's leadership in innovative education. The school is one of the few in Asia to offer a comprehensive biotechnology program that empowers students to address global challenges through applied science. About Concordia
More news about: Concordia International School Shanghai
Nov 11, 2025, 11:30 ET Medical Device Outsourcing Market to hit $386.08 Billion by 2033 - Grand View Research, Inc.
high standards of product safety and efficacy, further propelled by the surge in outsourcing of quality assurance activities by pharmaceutical, biotechnology, and medical device companies to specialized service providers. Request a free sample report of this
More news about: Grand View Research, Inc.
Nov 11, 2025, 11:01 ET Molecular Spectroscopy Market to Reach $6.4 billion, Globally, by 2034 at 5% CAGR: Allied Market Research
Molecular spectroscopy is widely applied across pharmaceutical, biotechnology, chemical, environmental, and food industries due to its ability to analyze molecular structures, identify compounds, and monitor chemical processes with high precision. Techniques
More news about: Allied Market Research
Nov 11, 2025, 09:27 ET MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
The litigation is focused on the propriety of MoonLake's statements about the trial design and data for SLK. The clinical stage biotechnology company is focused on skin inflammatory diseases driven by a cytokines known as IL-17A and IL-17F. Central to SLK's commercial
More news about: Hagens Berman Sobol Shapiro LLP
Nov 11, 2025, 09:18 ET Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering
About Decoy Therapeutics, Inc. Decoy Therapeutics is a preclinical-stage biotechnology company that is leveraging machine learning and artificial intelligence tools alongside high-speed synthesis techniques to rapidly design, engineer
More news about: Salarius Pharmaceuticals, Inc.
Nov 11, 2025, 09:00 ET Strategic Partnership Between Sanyou Bio and Yugong Bio to Accelerate Expansion in High-End Synthetic Enzyme Market
Powerful Synergy: Complementary Strengths Form a Solid Foundation for Cooperation Sanyou Bio is a biotechnology company focused on the discovery and development of innovative antibody drugs. Its internationally leading ultra-trillion-scale antibody library,
More news about: Sanyou Bio
Nov 11, 2025, 09:00 ET BioMarin to Participate at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England
website for a limited time following the conference. About BioMarinBioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San
More news about: BioMarin Pharmaceutical Inc.